NetworkNewsWire Releases Exclusive Audio Interview with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
16
NetworkNewsWire Releases Exclusive Audio Interview with Pressure BioSciences Inc. (PBIO)

NEW YORK, NY--(Marketwired - Oct 26, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company that delivers a new generation of social communication solutions for business, today announces the online availability of its interview with Pressure BioSciences Inc. ( OTCQB : PBIO ), a leader in the development and sale of innovative solutions for the worldwide life sciences industry.

The interview can be heard at http://NNW.fm/PBIO-Interview-October-2017

Kicking off the interview, NNW's Stuart Smith introduces Richard T. Schumacher, founder and CEO of Pressure BioSciences, who describes the unique technologies at play with the company's award-winning, high pressure table-top instruments.

"We supply instruments and consumables to life science laboratories all over the world," says Schumacher. "These are the laboratories that are aggressively looking for the next billion-dollar drug, the next cure, the next preventive strategy, the next vaccine."

Instruments designed and manufactured by Pressure BioSciences are constructed to handle extremely high pressure points, up to 100,000 pounds per square inch of hydrostatic pressure. Schumacher points out that everything in nature has its own pressure point, which means under the right pressure and temperature conditions every biological cell sample -- whether it is from a virus, bacterium, normal or cancerous cell, animal or plant -- can be placed under pressure to be broken open to release its biomolecules (e.g., DNA, RNA, proteins, lipids) for analysis. The company's patented high pressure cycling technology (PCT) provides researchers with the ability to exquisitely control the critical sample preparation process. PBI believes that there are as many as 500,000 researchers worldwide who need to break cells in their studies, and that many are using old, archaic methods to do so.

Pressure BioSciences recently received patents for its Ultra Shear Technology (UST), a process that has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Schumacher says this technology could provide a breakthrough when it comes to making cannabidiol (CBD) oil water soluble.

"We believe we can take CBD rich oil, put it through our system, break the oil down to very small droplets, and thus make it essentially water soluble, which means the bioavailability of CBD would dramatically increase," he says, noting the problem of making CBD oils water soluble has plagued the cannabis industry from the beginning.

Pressure BioSciences, which completed 2016 with $2 million in sales with only one salesperson on board, has recently added five more people to the sales staff -- and the team is diligently working to continue the company's progress in the industry. Its newest table-top, high-pressure instrument is a finalist in the 2017 R&D 100 Awards, which are often referred to as the "Oscars of Innovation". Furthermore, key opinion leaders around the globe are beginning to recognize the Barocycler 2320EXT instrument as a "must have" for laboratory research because of the many advantages the instrument has over its competitors, including a new USB output port where data generated by the instrument can be downloaded, making it a useful tool for FDA-required testing in biopharma quality control, a brand new application.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") ( OTCQB : PBIO ) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or "PCT") hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug development and design, bio-therapeutics characterization, soil & plant biology, forensics, and counter-bioterror applications. Major new focal market opportunities are emerging in the use of our patented, scalable, high-efficiency Ultra Shear Technology ("UST") to create stable nanoemulsions of otherwise immiscible fluids (such as oils and water), and to prepare higher quality, homogenized, extended shelf-life or room temperature stable, low-acid liquid foods that cannot be effectively prepared using existing technologies.

For more information, visit https://www.pressurebiosciences.com/

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today's market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer  

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements.

Communications Contact: NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 85

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 165

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 148

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 153

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Titans Rally: Stock Highlights You Can't Miss Today

Updated Category News Views 204

Market Overview Recent trading sessions in the U.S. saw mixed results. While the Dow Jones Industrial Average experienced a slight decline, the S&P 500 showed minimal movement. In contrast, the tech-centered Nasdaq showed a modest uptick as many companies presented their earnings. Federal Reserve Updates The Federal Reserve's decision to hold interest rates steady at...

Continue Reading
Investment Growth: Alphabet Stock's Journey Over Two Decades

Updated Category News Views 265

Understanding the Performance of Alphabet Stock Alphabet (NASDAQ: GOOGL) has consistently demonstrated remarkable growth, outpacing the market by an impressive 9.36% on an annualized basis. This translates to an average annual return of 18.3%, showcasing the company's ability to thrive even amid challenging economic conditions. With a market capitalization soaring to...

Continue Reading
Palantir Technologies Expands with 26 Partnerships in 15 Sectors

Updated Category News Views 885

Palantir's Remarkable Growth Journey Palantir Technologies Inc (NASDAQ: PLTR) has been making waves in the enterprise software landscape. In merely ten months, the company has successfully formed 26 partnerships across 15 different sectors, a feat that extends its reach well beyond its traditional defense-oriented image. This surge in collaboration indicates its...

Continue Reading
Bitcoin Market Dynamics Shift Amidst Emerging Trends

Updated Category News Views 148

Bitcoin Market Dynamics Shift Amidst Emerging Trends The financial markets are currently navigating through a phase of cautious optimism, with the leading indices showing modest gains. A notable exception to this trend is Bitcoin, which has recently displayed some volatility. After a significant breakout, Bitcoin encountered a sudden reverse, leading to concerns of a...

Continue Reading
Stifel Financial Corp. Announces Cash Dividends for Investors

Updated Category News Views 129

Stifel Financial Corporation's Dividend Announcement Stifel Financial Corp. announces a substantial cash dividend for its common stock shareholders, declaring a payout of $0.46 per share. This announcement comes as part of the company's regular financial strategy aimed at rewarding its shareholders. The payment is scheduled for September 16, with shareholders on record as...

Continue Reading